In Jin et al.'s (11) study, a single glutaminase inhibitor had limited the anti-cancer effect, and the dual inhibition of glutamine metabolism by targeting both glutaminase and glutamine transporter showed a promising therapeutic effect. Here, GLS is linked to cancer.